Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ January 28, 2023 ] TYR Sport Signs Prodigy Katie Grimes. Los Angeles Biotech News
  • [ January 27, 2023 ] Ayal Willner, MD, is recognized by Continental Who’s Who Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15(c) Announcement – Rule 15 Proposal to Horizon Equity Award Holders and Participants in the Horizon Employee Share Purchase Plan Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15 (c) Announcement – Horizon Therapeutics plc Los Angeles Biotech News
  • [ January 27, 2023 ] Research Technician I – Zymo Research – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsDermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

August 26, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis
LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

Click to view original post

Previous

ChromaDex to Present at the LD 500 Virtual Investor Conference

Next

A Forbion-funded startup bought the rights to Amgen’s CETP inhibitor, and is giving the cholesterol drug another go

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered